Zobrazeno 1 - 10
of 163
pro vyhledávání: '"GF Sanz"'
Autor:
GF Sanz, MA Sanz, T Vallespi, MC Canizo, M Torrabadella, S Garcia, D Irriguible, JF San Miguel
Publikováno v:
Blood. 74:395-408
Therapy planning in patients with myelodysplastic syndromes (MDSs) is complicated by its high prognostic heterogeneity. Forty-one patient and disease characteristics at onset of 370 patients with MDS were analyzed to identify significant prognostic f
Autor:
Barragán E, Bonanad S, Ja, López, Martín G, Martínez J, Gf, Sanz, Gomis F, Ml, Pérez, Ml, Senent, Luis Larrea, Bolufer P, Ma, Sanz
Publikováno v:
Europe PubMed Central
This study describes a molecular method of reverse transcription polymerase chain reaction (RT-PCR) to detect the rearrangement PML/RAR alpha in acute promyelocytic leukaemia (APL) in order to assess its specificity and sensibility, and to evaluate i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ee156626686d9f208d68aeb53caf52b6
http://europepmc.org/abstract/med/8755206
http://europepmc.org/abstract/med/8755206
Autor:
López F, Jarque I, Martín G, Gf, Sanz, Palau J, Martínez J, de la Rubia J, Larrea L, Arnao M, Solves P, Cervera J, Ml, Martínez, Javier Pemán, Gobernado M, Ma, Sanz
Publikováno v:
Europe PubMed Central
Invasive fungal infections (IFI) are severe infectious complications frequently observed in patients with hematological disorders. The aims of this study were to analyse the characteristics of this particular type of infection in a large series of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::bd480b12d5698cec6fcd46449f4cb46c
http://europepmc.org/abstract/med/9608494
http://europepmc.org/abstract/med/9608494
Autor:
Bernard E; Gustave Roussy, France., Hasserjian RP; Massachusetts General Hospital, Boston, Massachusetts, United States., Greenberg PL; Stanford University Cancer Institute, Stanford, California, United States., Arango Ossa JE; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Creignou M; Karolinska Institutet, Huddinge, Sweden., Tuechler H; Independent researcher., Gutiérrez-Abril J; MSKCC, NYC, New York, United States., Domenico D; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Medina-Martinez JS; Memorial Sloan Kettering Cancer Center, New york, New York, United States., Levine MF; Memorial Sloan Kettering, New York, New York, United States., Liosis K; Memorial Sloan Kettering Cancer Center, New york, New York, United States., Farnoud N; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Sirenko M; Memorial Sloan Kettering Cancer Center, New York City, New York, United States., Jädersten M; Karolinska Institutet, Stockholm, Sweden., Germing U; Heinrich-Heine-University, Duesseldorf, Germany., Sanz GF; Hospital Universitario y Politécnico La Fe, Valencia, Spain, Health Research Institute La Fe, Valencia, Spain, and CIBERONC, Instituto de Salud Carlos III, Madrid, Spain, Valencia, Spain., Van de Loosdrecht AA; VU University Medical Center, Amsterdam, Netherlands., Nannya Y; The University of Tokyo, Tokyo, Japan., Kosmider O; Hopital Cochin, Paris, France., Follo MY; University of Bologna, Bologna, Italy., Thol FR; Hannover Medical School, Hannover, Germany., Zamora L; Hematología. ICO Badalona - HGTiP. Institut d'Investigació contra la Leucèmia Josep Carreras, Badalona, Spain., Pinheiro RF; Federal University of Ceara, Fortaleza, Brazil., Pellagatti A; University of Oxford, Oxford, United Kingdom., Elias HK; National Institutes of Health, Bethesda, Maryland, United States., Haase DT; University Medical Center, Goettingen, Germany., Ganster C; University of Goettingen, Göttingen, Germany., Ades L; Hopital Saint Louis, Paris, France., Tobiasson M; Karolinska Institute; Karolinska University Hospital, Stockholm, Sweden., Palomo L; Institut Catala d'Oncololgia, Badalona, Spain., Della Porta MG; IRCCS Humanitas Research Hospital & Humanitas University, Rozzano - Milan, Italy., Fenaux P; hôpital St Louis, Paris, PARIS, France., Belickova M; The Institute of Hematology and Blood Transfusion, Prague, Czech Republic., Savona MR; Vanderbilt University School of Medicine, Nashville, Tennessee, United States., Klimek V; Syros Pharmaceuticals, Cambridge, Massachusetts, United States., Santos FPS; Hospital Israelita Albert Einstein, Sao Paulo, Brazil., Boultwood J; University of Oxford, Oxford, United Kingdom., Kotsianidis I; DUTH, ALEXPOLIS, Greece., Santini V; MDS Unit, University of Florence, Florence, Italy., Sole F; Institut de Recerca contra la Leucemia Josep Carreras. Barcelona, Spain, Badalona, Spain., Platzbecker U; University Hospital Leipzig, Department of Hematology and Cell Therapy, Leipzig, Germany., Heuser M; Hannover Medical School, Hannover, Germany., Valent P; Medical University of Vienna, Vienna, Austria., Finelli C; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy, Bologna, Italy., Voso MT; Tor Vergata, Rome, Italy., Shih LY; Chang Gung Memorial Hospital-Linkou, Taipei, Taiwan., Fontenay M; Université de Paris, AP-HP Hôpital Cochin, Paris, France., Jansen JH; UMC-St Radboud, Nijmegen, Netherlands., Cervera J; Hospital Universitario La Fe, Valencia, Spain., Gattermann N; Heinrich Heine University Düsseldorf, Duesseldorf, Germany., Ebert BL; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Bejar R; University of California, San Diego, La Jolla, California, United States., Malcovati L; University of Pavia, Pavia, Italy., Ogawa S; Kyoto University, Kyoto, Japan., Cazzola M; University of Pavia, Pavia, Italy., Hellstrom-Lindberg ES; Karolinska Institutet, Stockholm, Sweden., Papaemmanuil E; MSKCC, NYC, United Kingdom.
Publikováno v:
Blood [Blood] 2024 Jul 03. Date of Electronic Publication: 2024 Jul 03.
Autor:
Cordón L; Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106, Valencia, 46026, Spain. lou.cordon@gmail.com.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain. lou.cordon@gmail.com., Chorão P; Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106, Valencia, 46026, Spain.; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Martín-Herreros B; Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106, Valencia, 46026, Spain., Montoro J; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Balaguer A; Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106, Valencia, 46026, Spain.; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Guerreiro M; Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106, Valencia, 46026, Spain.; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Villalba M; Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106, Valencia, 46026, Spain.; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Facal A; Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106, Valencia, 46026, Spain.; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Asensi P; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Solves P; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Gómez I; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain.; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Santiago M; Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106, Valencia, 46026, Spain.; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Lamas B; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Bataller A; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Granados P; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Sempere A; Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106, Valencia, 46026, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain.; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Sanz GF; Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106, Valencia, 46026, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain.; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Sanz MA; Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106, Valencia, 46026, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain.; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Sanz J; Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106, Valencia, 46026, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain.; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Publikováno v:
Annals of hematology [Ann Hematol] 2024 Jul; Vol. 103 (7), pp. 2475-2484. Date of Electronic Publication: 2024 Apr 18.
Autor:
Sirenko M; Memorial Sloan Kettering Cancer Center, New York City, New York, United States., Bernard E; Gustave Roussy, France., Creignou M; Karolinska Institutet, Huddinge, Sweden., Domenico D; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Farina A; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Arango Ossa JE; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Kosmider O; Hopital Cochin, Paris, France., Hasserjian RP; Massachusetts General Hospital, Boston, Massachusetts, United States., Jädersten M; Karolinska Institutet, Stockholm, Sweden., Germing U; Heinrich-Heine-University, Duesseldorf, Germany., Sanz GF; Hospital Universitario y Politécnico La Fe, Valencia, Spain, Health Research Institute La Fe, Valencia, Spain, and CIBERONC, Instituto de Salud Carlos III, Madrid, Spain, Valencia, Spain., van de Loosdrecht AA; Amsterdam UMC location VUmc, Amsterdam, Netherlands., Gurnari C; Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States., Follo MY; University of Bologna, Bologna, Italy., Thol FR; Hannover Medical School, Hannover, Germany., Zamora L; Hematología. ICO Badalona - HGTiP. Institut d'Investigació contra la Leucèmia Josep Carreras, Badalona, Spain., Pinheiro RF; Federal University of Ceara, Fortaleza, Brazil., Pellagatti A; University of Oxford, Oxford, United Kingdom., Elias HK; National Institutes of Health, Bethesda, Maryland, United States., Haase DT; University Medical Center, Goettingen, Germany., Sander B; Karolinska Institutet and Karolinska University Hospital Huddinge, Stockholm, Sweden., Orna E; Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Zoldan K; Department of Medicine 1, Haematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Medical Center Leipzig, Leipzig, Germany, Leipzig, Germany., Eder LN; University of Goettingen, Goettingen, Germany., Sperr WR; Dept. of. Int.Med.I, Div.of Hematology, Vienna, Austria., Thalhammer R; Medical University of Vienna, Vienna, Austria., Ganster C; University of Goettingen, Göttingen, Germany., Adès L; AP-HP, Hôpital Saint Louis and University of Paris, and INSERM U944, Paris, France., Tobiasson M; Karolinska Institute; Karolinska University Hospital, Stockholm, Sweden., Palomo L; Institut Catala d'Oncololgia, Badalona, Spain., Della Porta MG; IRCCS Humanitas Research Hospital & Humanitas University, Rozzano - Milan, Italy., Huberman KH; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Fenaux P; hôpital St Louis, Paris, PARIS, France., Belickova M; The Institute of Hematology and Blood Transfusion, Prague, Czech Republic., Savona MR; Vanderbilt University School of Medicine, Nashville, Tennessee, United States., Klimek V; Memorial Sloan-Kettering Cancer Center, New York, New York, United States., Santos FPS; Hospital Israelita Albert Einstein, Sao Paulo, Brazil., Boultwood J; University of Oxford, Oxford, United Kingdom., Kotsianidis I; DUTH, ALEXPOLIS, Greece., Santini V; MDS Unit, University of Florence, Florence, Italy., Sole F; Institut de Recerca contra la Leucemia Josep Carreras. Barcelona, Spain, Badalona, Spain., Platzbecker U; University Hospital Leipzig, Department of Hematology and Cell Therapy, Leipzig, Germany., Heuser M; Hannover Medical School, Hannover, Germany., Valent P; Medical University of Vienna, Vienna, Austria., Finelli C; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy, Bologna, Italy., Voso MT; Tor Vergata, Rome, Italy., Shih LY; Chang Gung Memorial Hospital-Linkou, Taipei, Taiwan., Ogawa S; Kyoto University, Kyoto, Japan., Fontenay M; Université Paris Cité, AP-HP, Paris, France., Jansen JH; UMC-St Radboud, Nijmegen, Netherlands., Cervera J; Hospital Universitario La Fe, Valencia, Spain., Ebert BL; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Bejar R; UCSD, La Jolla, California, United States., Greenberg PL; Stanford University Cancer Center, Stanford, California, United States., Gattermann N; Heinrich Heine University Düsseldorf, Duesseldorf, Germany., Malcovati L; University of Pavia, Pavia, Italy., Cazzola M; University of Pavia, Pavia, Italy., Beck DB; NYU langone, New York, New York, United States., Hellstrom-Lindberg ES; Karolinska Institutet, Stockholm, Sweden., Papaemmanuil E; Memorial Sloan Kettering Cancer Center, United States.
Publikováno v:
Blood [Blood] 2024 Apr 30. Date of Electronic Publication: 2024 Apr 30.
Autor:
Stojkov I; Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria., Conrads-Frank A; Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria., Rochau U; Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria., Arvandi M; Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria., Koinig KA; Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, Innsbruck, Austria., Schomaker M; Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria.; Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa., Mittelman M; Department of Medicine A, Tel Aviv Sourasky (Ichilov) Medical Center and Sackler Medical Faculty, Tel Aviv University, Tel Aviv, Israel., Fenaux P; Service d'Hématologie Séniors, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris and Université Paris 7, Paris, France., Bowen D; St. James's Institute of Oncology, Leeds Teaching Hospitals, Leeds, United Kingdom., Sanz GF; Department of Haematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain., Malcovati L; Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy., Langemeijer S; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Germing U; Department of Haematology, Oncology and Clinical Immunology, Universitätsklinik Düsseldorf, Düsseldorf, Germany., Madry K; Department of Haematology, Oncology and Internal Medicine, Warszawa Medical University, Warsaw, Poland., Guerci-Bresler A; Service d'Hématologie Clinique, Centre Hospitalier Universitaire Brabois, Nancy, France., Culligan DJ; Department of Haematology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom., Kotsianidis I; Department of Hematology, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece., Sanhes L; Haematology Department of Perpignan, Saint Jean Hospital, Perpignan, France., Mills J; Worcestershire Acute Hospitals NHS Trust and University Hospitals Birmingham NHS Foundation Trust, Worcester, United Kingdom., Puntscher S; Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria., Schmid D; Division for Quantitative Methods in Public Health and Health Services Research, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria., van Marrewijk C; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Smith A; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom., Efficace F; Health Outcomes Research Unit, Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA), Rome, Italy., de Witte T; Department of Tumor Immunology - Nijmegen Center for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Stauder R; Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, Innsbruck, Austria., Siebert U; Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria.; Division of Health Technology Assessment, ONCOTYROL - Center for Personalized Cancer Medicine, Innsbruck, Austria.; Center for Health Decision Science, Departments of Epidemiology and Health Policy & Management, Harvard Chan School of Public Health, Boston, MA.; Institute for Technology Assessment and Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Publikováno v:
Blood advances [Blood Adv] 2023 Jun 27; Vol. 7 (12), pp. 2772-2783.
Autor:
Stahl M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA., Abdel-Wahab O; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Wei AH; Peter MacCallum Cancer Centre, Royal Melbourne Hospital, University of Melbourne and Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia., Savona MR; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Xu ML; Departments of Pathology & Laboratory Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT., Xie Z; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL., Taylor J; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL., Starczynowski D; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH., Sanz GF; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Health Research Institute La Fe, Valencia, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain., Sallman DA; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL., Santini V; MDS Unit, AOUC, University of Florence, Florence, Italy., Roboz GJ; Weill Cornell Medicine and The New York Presbyterian Hospital, New York, NY., Patnaik MM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Padron E; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL., Odenike O; The University of Chicago, Chicago, IL., Nazha A; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA., Nimer SD; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL., Majeti R; Division of Hematology, Department of Medicine, Cancer Institute, Stanford University School of Medicine, Stanford, CA., Little RF; National Cancer Institute, National Institutes of Health, Bethesda, MD., Gore S; National Cancer Institute, National Institutes of Health, Bethesda, MD., List AF; Precision BioSciences, Inc, Durham, NC., Kutchroo V; Evergrande Center for Immunologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA., Komrokji RS; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL., Kim TK; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Kim N; National Cancer Institute, National Institutes of Health, Bethesda, MD., Hourigan CS; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Hasserjian RP; Department of Pathology, Massachusetts General Hospital, Boston, MA., Halene S; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT., Griffiths EA; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Greenberg PL; Division of Hematology, Department of Medicine, Cancer Institute, Stanford University School of Medicine, Stanford, CA., Figueroa M; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL., Fenaux P; Hôpital Saint Louis, Paris, France., Efficace F; Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy., DeZern AE; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, MD., Della Porta MG; Humanitas Clinical and Research Center & Humanitas University, Department of Biomedical Sciences, Milan, Italy., Daver NG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Churpek JE; Department of Hematology, Oncology, and Palliative Care, Carbone Cancer Center, The University of Wisconsin-Madison, Madison, WI., Carraway HE; Leukemia Program, Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH., Brunner AM; Center for Leukemia, Massachusetts General Hospital, Boston, MA., Borate U; Division of Hematology, Department of Internal Medicine, James Cancer Center, Ohio State University, Columbus, OH., Bennett JM; Hematopathology Division, Departments of Pathology and Medicine, University of Rochester Medical Center, Rochester, NY., Bejar R; Division of Hematology and Oncology, Moores Cancer Center, UC San Diego, La Jolla, CA., Boultwood J; Blood Cancer UK Molecular Haematology Unit, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, UK., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Bewersdorf JP; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Platzbecker U; Department of Hematology and Cellular Therapy, Medical Clinic and Policlinic I, Leipzig University Hospital, Leipzig, Germany., Steensma DP; Novartis Institutes of BioMedical Research., Sekeres MA; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL., Buckstein RJ; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada., Zeidan AM; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT.
Publikováno v:
Blood advances [Blood Adv] 2023 Jun 27; Vol. 7 (12), pp. 2709-2714.
Autor:
Zeidan AM; Yale University & Yale Cancer Center, New Haven, CT 06510, USA., Giagounidis A; Marien Hospital Düsseldorf, Düsseldorf, 40479, Germany., Sekeres MA; Division of Hematology, Sylvester Cancer Center, University of Miami, Miami, FL 33065, USA., Xiao Z; Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, 300020, China., Sanz GF; Hospital Universitario y Politécnico La Fe, Valencia, 46026, Spain.; Health Research Institute La Fe (IIS La Fe), Valencia, 46026, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, 28029, Spain., Hoef MV; Novartis Pharma AG, Basel, 4056, Switzerland., Ma F; Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA., Hertle S; Novartis Pharma AG, Basel, 4056, Switzerland., Santini V; MDS Unit, Hematology, University of Florence, Florence, 50121, Italy.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2023 Mar; Vol. 19 (9), pp. 631-642. Date of Electronic Publication: 2023 Apr 21.
Autor:
Cruz D; Hematology Department, Institut Català d'Oncologia - Hospital Dr. Josep Trueta, Institut d'Investigació Biomèdica de Girona (IDIBGI), Josep Carreras Research Institute, Girona, Spain., Rodríguez-Romanos R; Hematology Department, Institut Català d'Oncologia - Hospital Dr. Josep Trueta, Institut d'Investigació Biomèdica de Girona (IDIBGI), Josep Carreras Research Institute, Girona, Spain., González-Bartulos M; Hematology Department, Institut Català d'Oncologia - Hospital Dr. Josep Trueta, Institut d'Investigació Biomèdica de Girona (IDIBGI), Josep Carreras Research Institute, Girona, Spain., García-Cadenas I; Hematology Department, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau, Universitat Autónoma de Barcelona, Barcelona, Spain., de la Cámara R; Hematology Department, Hospital La Princesa, Madrid, Spain., Heras I; Hematology Department, Hospital General Universitario Morales Meseguer, Murcia, Spain., Buño I; Hematology Department and Genomics Unit, Hospital General Universitario Gregorio Marañón, Gregorio Marañón Health Research Institute (IiSGM), Complutense University, Madrid, Spain., Santos N; Hematology Department, Institut Català d'Oncologia - Hospital Dr. Josep Trueta, Institut d'Investigació Biomèdica de Girona (IDIBGI), Josep Carreras Research Institute, Girona, Spain., Lloveras N; Hematology Department, Institut Català d'Oncologia - Hospital Dr. Josep Trueta, Institut d'Investigació Biomèdica de Girona (IDIBGI), Josep Carreras Research Institute, Girona, Spain.; Department of Medicine, Universitat de Girona, Girona, Spain., Velarde P; Hematology Department, Institut Català d'Oncologia - Hospital Dr. Josep Trueta, Institut d'Investigació Biomèdica de Girona (IDIBGI), Josep Carreras Research Institute, Girona, Spain., Tuset E; Hematology Department, Institut Català d'Oncologia - Hospital Dr. Josep Trueta, Institut d'Investigació Biomèdica de Girona (IDIBGI), Josep Carreras Research Institute, Girona, Spain., Martínez C; Hematology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., González M; Hematology Department, Hospital Clínico Universitario, Salamanca, Spain., Sanz GF; Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Ferrá C; Hematology Department, Institut Català d'Oncologia - Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Badalona, Spain., Sampol A; Hematology Department, Hospital Universitari Son Espases, IdISBa, Palma de Mallorca, Spain., Coll R; Hematology Department, Institut Català d'Oncologia - Hospital Dr. Josep Trueta, Institut d'Investigació Biomèdica de Girona (IDIBGI), Josep Carreras Research Institute, Girona, Spain.; Department of Medicine, Universitat de Girona, Girona, Spain., Pérez-Simón JA; Hematology Department, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, Universidad de Sevilla, Sevilla, Spain., López-Jiménez J; Hematology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Jurado M; Hematology Department, Hospital Universitario Virgen de las Nieves, Granada, Spain., Gallardo D; Hematology Department, Institut Català d'Oncologia - Hospital Dr. Josep Trueta, Institut d'Investigació Biomèdica de Girona (IDIBGI), Josep Carreras Research Institute, Girona, Spain.; Department of Medicine, Universitat de Girona, Girona, Spain.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Jan 20; Vol. 14, pp. 1066393. Date of Electronic Publication: 2023 Jan 20 (Print Publication: 2023).